Donald J. McMahon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Donald J. McMahon has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Emily Margaret Stein
Hospital for Special Surgery, New York, NY, USA
5 shared publications - Jeri W. Nieves
Skeletal Health and Orthopaedic Research Program (SHORE), Hospital for Special Surgery , New York, NY
4 shared publications Vicki Addesso
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY
4 shared publications- Aviva B. Sopher
Division of Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York
3 shared publications Elizabeth Shane
Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
3 shared publicationsAdrienne Taylor Gerken
2 shared publications
Latest Publications
- 18 November 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Bone Phenotype by HR-pQCT Relates to Risk of Skeletal Complications After Spinal Fusion Surgery
Spine fusion is one of the most common, complex orthopedic procedures. While osteoporosis is a risk factor for post-operative complications, DXA has limited ability to detect bone quality deficits in this population. Recently, three discrete bone microarchitecture phenotypes have been characterized by high-resolution peripheral quantitative CT (HR-pQCT) and related to fracture risk: Healthy, Low Volume (smaller cross-sectional area and trabecular abnormalities) and Low Density (cortical and trabecular abnormalities; greatest fracture risk). In this prospective cohort of spine fusion patients, pre-operative bone phenotypes were assessed by HR-pQCT (XtremeCT II, Scanco Medical) at the distal radius and tibia and related to post-operative skeletal complications. Of 167 patients, mean age was 63±11 years, 54% were female. Mean Z-scores by DXA were normal. Phenotypic classification was Low Density (n=42), Low Volume (n=44) and Healthy (n=81). Median post-operative follow-up was 42 months. Skeletal complications occurred in 40% (n=68), 60% of those with Low Density had complications, compared to 30% of Low Volume and 37% of Healthy. Individuals with Low Density phenotype had a greater risk of complications compared to those with Low Volume phenotype (HR 2.46 95% CI 1.26-4.82; p=0.009) and there was a trend toward greater risk of complications compared to those classified as Healthy (HR 1.66 95% CI 0.97-2.82; p=0.06). Complication risk in Low Density compared to the combined categories of Low Volume and Healthy was greater in unadjusted (HR 1.90 95% CI 1.16–3.12, p=0.01) and sex-adjusted analyses (HR 2.18 95% CI 1.29–3.69, p=0.004). In summary, pre-operative bone phenotype was related to risk of skeletal complications after spine fusion. Low Density phenotype, encompassing both cortical and trabecular deficits was associated with the greatest risk of complications. These findings, the first relating microarchitectural phenotype to post-operative outcomes, may help foster better identification of spine fusion candidates at high risk for complications.
- 18 November 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Bone Phenotype by HR-pQCT Relates to Risk of Skeletal Complications After Spinal Fusion Surgery
Spine fusion is one of the most common, complex orthopedic procedures. While osteoporosis is a risk factor for post-operative complications, DXA has limited ability to detect bone quality deficits in this population. Recently, three discrete bone microarchitecture phenotypes have been characterized by high-resolution peripheral quantitative CT (HR-pQCT) and related to fracture risk: Healthy, Low Volume (smaller cross-sectional area and trabecular abnormalities) and Low Density (cortical and trabecular abnormalities; greatest fracture risk). In this prospective cohort of spine fusion patients, pre-operative bone phenotypes were assessed by HR-pQCT (XtremeCT II, Scanco Medical) at the distal radius and tibia and related to post-operative skeletal complications. Of 167 patients, mean age was 63±11 years, 54% were female. Mean Z-scores by DXA were normal. Phenotypic classification was Low Density (n=42), Low Volume (n=44) and Healthy (n=81). Median post-operative follow-up was 42 months. Skeletal complications occurred in 40% (n=68), 60% of those with Low Density had complications, compared to 30% of Low Volume and 37% of Healthy. Individuals with Low Density phenotype had a greater risk of complications compared to those with Low Volume phenotype (HR 2.46 95% CI 1.26-4.82; p=0.009) and there was a trend toward greater risk of complications compared to those classified as Healthy (HR 1.66 95% CI 0.97-2.82; p=0.06). Complication risk in Low Density compared to the combined categories of Low Volume and Healthy was greater in unadjusted (HR 1.90 95% CI 1.16–3.12, p=0.01) and sex-adjusted analyses (HR 2.18 95% CI 1.29–3.69, p=0.004). In summary, pre-operative bone phenotype was related to risk of skeletal complications after spine fusion. Low Density phenotype, encompassing both cortical and trabecular deficits was associated with the greatest risk of complications. These findings, the first relating microarchitectural phenotype to post-operative outcomes, may help foster better identification of spine fusion candidates at high risk for complications.
- Open Access
- 20 August 2026
- Published by Springer Nature in Osteoporosis International
- p. 1-14
Abaloparatide and pelvic fracture healing: a phase 2 randomized placebo-controlled trial
- 20 August 2026
- Published by Springer Nature in Osteoporosis International
- p. 1-14
Open AccessAbaloparatide and pelvic fracture healing: a phase 2 randomized placebo-controlled trial
- 26 March 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Preoperative MRI bone texture is associated with complications after spine fusion
Bone quality is a critical determinant of outcomes following spine fusion surgery. However, patients with skeletal deficits are often only identified intraoperatively when there are unexpected problems with hardware placement, or postoperatively, when bone-related complications occur. MRI is routinely performed for diagnosis and surgical planning, making a technique based on clinical MRI ideal to opportunistically evaluate bone health. Texture analysis of trabecular bone from MRI has recently emerged as a biomarker of bone quality. This prospective study related preoperative MRI-based texture from standard clinical images and areal BMD (aBMD) by DXA to postoperative outcomes following spine fusion. T1-weighted MR images were acquired from patients undergoing instrumented lumbar spine fusion. The following texture features were derived within the L1-L5 vertebral bodies to characterize the local distribution and spatial organization of signal intensity: contrast (variability) and entropy (disorder) for which higher values reflect high heterogeneity; angular second moment (ASM; uniformity) and inverse difference moment (IDM; homogeneity) for which higher values reflect low heterogeneity. Of 72 patients enrolled, mean age was 63 years (54% female). Patients were followed for a median of 13 months after surgery. Skeletal complications occurred in 27 patients (38%); proximal junctional kyphosis and screw loosening were the most common. There was no association between new complications and aBMD at any site. In contrast, patients who developed postoperative complications had greater preoperative MRI-texture heterogeneity than those who did not, specifically higher contrast (26%) and entropy (12%), lower ASM (−13%) and IDM (−25%, p < .01 for all). In summary, greater heterogeneity of preoperative bone texture from clinical MRIs was associated with skeletal complications following spine fusion. These findings support this novel method as an opportunistic screening technique to foster earlier identification of high-risk patients who would benefit from interventions to improve surgical outcomes.
- 26 March 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
Preoperative MRI bone texture is associated with complications after spine fusion
Bone quality is a critical determinant of outcomes following spine fusion surgery. However, patients with skeletal deficits are often only identified intraoperatively when there are unexpected problems with hardware placement, or postoperatively, when bone-related complications occur. MRI is routinely performed for diagnosis and surgical planning, making a technique based on clinical MRI ideal to opportunistically evaluate bone health. Texture analysis of trabecular bone from MRI has recently emerged as a biomarker of bone quality. This prospective study related preoperative MRI-based texture from standard clinical images and areal BMD (aBMD) by DXA to postoperative outcomes following spine fusion. T1-weighted MR images were acquired from patients undergoing instrumented lumbar spine fusion. The following texture features were derived within the L1-L5 vertebral bodies to characterize the local distribution and spatial organization of signal intensity: contrast (variability) and entropy (disorder) for which higher values reflect high heterogeneity; angular second moment (ASM; uniformity) and inverse difference moment (IDM; homogeneity) for which higher values reflect low heterogeneity. Of 72 patients enrolled, mean age was 63 years (54% female). Patients were followed for a median of 13 months after surgery. Skeletal complications occurred in 27 patients (38%); proximal junctional kyphosis and screw loosening were the most common. There was no association between new complications and aBMD at any site. In contrast, patients who developed postoperative complications had greater preoperative MRI-texture heterogeneity than those who did not, specifically higher contrast (26%) and entropy (12%), lower ASM (−13%) and IDM (−25%, p < .01 for all). In summary, greater heterogeneity of preoperative bone texture from clinical MRIs was associated with skeletal complications following spine fusion. These findings support this novel method as an opportunistic screening technique to foster earlier identification of high-risk patients who would benefit from interventions to improve surgical outcomes.
- Open Access
- 21 October 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (23)
Effects of iron repletion on brain iron content, myelination, neural network activation, and cognition
BACKGROUND: Blood donation increases the risk of iron deficiency, but its effect on brain iron, myelination, and neurocognition remains unclear. METHODS: This ancillary study enrolled 67 iron-deficient blood donors, 19–73 years of age, participating in a double-blind, randomized trial. After donating blood, positive and negative susceptibility were measured using quantitative susceptibility mapping (QSM) MRI to estimate brain iron and myelin levels, respectively. Furthermore, neurocognitive function was evaluated using the NIH Toolbox, and neural network activation patterns were assessed during neurocognitive tasks using functional MRI (fMRI). Donors were randomized to i.v. iron repletion (1 g iron) or placebo, and outcome measures repeated approximately 4 months later. RESULTS: Iron repletion corrected systemic iron deficiency and led to trends toward increased whole brain iron ( P = 0.04) and myelination ( P = 0.02), with no change in the placebo group. Although overall cognitive performance did not differ significantly between groups, iron-treated participants showed improved engagement of functional neural networks (e.g., memory pattern activation during speed tasks, P < 0.001). Brain region-specific changes in iron and myelin correlated with cognitive performance: iron in the putamen correlated with working memory scores ( P < 0.01), and thalamic myelination correlated with attention and inhibitory control ( P < 0.01). CONCLUSION: Iron repletion in iron-deficient blood donors may influence brain iron, myelination, and function, with region-specific changes in iron and myelination linked to distinct cognitive domains. REGISTRATION: ClinicalTrials.gov NCT02990559 FUNDING: This work was funded by the NIH.
- 21 October 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (23)
Open AccessEffects of iron repletion on brain iron content, myelination, neural network activation, and cognition
BACKGROUND: Blood donation increases the risk of iron deficiency, but its effect on brain iron, myelination, and neurocognition remains unclear. METHODS: This ancillary study enrolled 67 iron-deficient blood donors, 19–73 years of age, participating in a double-blind, randomized trial. After donating blood, positive and negative susceptibility were measured using quantitative susceptibility mapping (QSM) MRI to estimate brain iron and myelin levels, respectively. Furthermore, neurocognitive function was evaluated using the NIH Toolbox, and neural network activation patterns were assessed during neurocognitive tasks using functional MRI (fMRI). Donors were randomized to i.v. iron repletion (1 g iron) or placebo, and outcome measures repeated approximately 4 months later. RESULTS: Iron repletion corrected systemic iron deficiency and led to trends toward increased whole brain iron ( P = 0.04) and myelination ( P = 0.02), with no change in the placebo group. Although overall cognitive performance did not differ significantly between groups, iron-treated participants showed improved engagement of functional neural networks (e.g., memory pattern activation during speed tasks, P < 0.001). Brain region-specific changes in iron and myelin correlated with cognitive performance: iron in the putamen correlated with working memory scores ( P < 0.01), and thalamic myelination correlated with attention and inhibitory control ( P < 0.01). CONCLUSION: Iron repletion in iron-deficient blood donors may influence brain iron, myelination, and function, with region-specific changes in iron and myelination linked to distinct cognitive domains. REGISTRATION: ClinicalTrials.gov NCT02990559 FUNDING: This work was funded by the NIH.
- Open Access
- 29 July 2025
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 9 (9) , ziaf126
Bone texture by clinical magnetic resonance imaging is directly related to bone tissue maturity by Fourier-transform infrared spectroscopy
Opportunistic screening for osteoporosis using images acquired for other purposes is a burgeoning area that may be of particular utility for the identification of surgical candidates with poor bone health. Texture analysis of clinical MRIs can be used to evaluate the heterogeneity of trabecular bone as a potential metric of bone quality. This cohort study investigated relationships between MRI-based vertebral trabecular bone texture and material properties by Fourier-transform infrared (FTIR) spectroscopy. We hypothesized that texture features from preoperative MRI images would reflect vertebral bone mineralization and collagen properties. In a cohort of 30 postmenopausal women (mean age 65) undergoing spine fusion surgery, T1-weighted MRI images were obtained using standard clinical sequences. A gray-level co-occurrence matrix was used to characterize the distribution and spatial organization of voxel intensities and derive texture features, including inverse difference moment, feature correlation, and contrast. Lumbar vertebral bone biopsies were obtained intraoperatively and analyzed with FTIR spectroscopy to assess composition, including metrics of mineral maturity (acid phosphate and carbonate:phosphate ratio). We found that vertebral trabecular bone texture by MRI was related to directly measured bone material properties: more heterogeneous texture was associated with less mature bone. Women with lower inverse difference moment had higher acid phosphate (r = −0.43, p < .02). Similarly, women with lower feature correlation had higher acid phosphate (r = −0.39, p < .04) and higher carbonate: phosphate (r = −0.47, p < .01). Women with higher contrast had higher acid phosphate (r = 0.381, p < .04). Our results suggest that preoperative MRI texture may predict intraoperative bone properties, specifically FTIR metrics of tissue age that may reflect local remodeling or microdamage repair processes. This finding supports the potential of MRI as a screening tool to identify individuals with abnormal bone quality.
- 29 July 2025
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 9 (9) , ziaf126
Open AccessBone texture by clinical magnetic resonance imaging is directly related to bone tissue maturity by Fourier-transform infrared spectroscopy
Opportunistic screening for osteoporosis using images acquired for other purposes is a burgeoning area that may be of particular utility for the identification of surgical candidates with poor bone health. Texture analysis of clinical MRIs can be used to evaluate the heterogeneity of trabecular bone as a potential metric of bone quality. This cohort study investigated relationships between MRI-based vertebral trabecular bone texture and material properties by Fourier-transform infrared (FTIR) spectroscopy. We hypothesized that texture features from preoperative MRI images would reflect vertebral bone mineralization and collagen properties. In a cohort of 30 postmenopausal women (mean age 65) undergoing spine fusion surgery, T1-weighted MRI images were obtained using standard clinical sequences. A gray-level co-occurrence matrix was used to characterize the distribution and spatial organization of voxel intensities and derive texture features, including inverse difference moment, feature correlation, and contrast. Lumbar vertebral bone biopsies were obtained intraoperatively and analyzed with FTIR spectroscopy to assess composition, including metrics of mineral maturity (acid phosphate and carbonate:phosphate ratio). We found that vertebral trabecular bone texture by MRI was related to directly measured bone material properties: more heterogeneous texture was associated with less mature bone. Women with lower inverse difference moment had higher acid phosphate (r = −0.43, p < .02). Similarly, women with lower feature correlation had higher acid phosphate (r = −0.39, p < .04) and higher carbonate: phosphate (r = −0.47, p < .01). Women with higher contrast had higher acid phosphate (r = 0.381, p < .04). Our results suggest that preoperative MRI texture may predict intraoperative bone properties, specifically FTIR metrics of tissue age that may reflect local remodeling or microdamage repair processes. This finding supports the potential of MRI as a screening tool to identify individuals with abnormal bone quality.
- Open Access
- 22 December 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (25) , 2730-2739
A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being
Although altruistic regular blood donors are vital for the blood supply, many become iron deficient from donation-induced iron loss. The effects of blood donation–induced iron deficiency on red cell transfusion quality or donor cognition are unknown. In this double-blind, randomized trial, adult iron-deficient blood donors (n = 79; ferritin < 15 μg/L and zinc protoporphyrin >60 μMol/mol heme) who met donation qualifications were enrolled. A first standard blood donation was followed by the gold-standard measure for red cell storage quality: a 51-chromium posttransfusion red cell recovery study. Donors were then randomized to intravenous iron repletion (1 g low-molecular-weight iron dextran) or placebo. A second donation ∼5 months later was followed by another recovery study. Primary outcome was the within-subject change in posttransfusion recovery. The primary outcome measure of an ancillary study reported here was the National Institutes of Health Toolbox–derived uncorrected standard Cognition Fluid Composite Score. Overall, 983 donors were screened; 110 were iron-deficient, and of these, 39 were randomized to iron repletion and 40 to placebo. Red cell storage quality was unchanged by iron repletion: mean change in posttransfusion recovery was 1.6% (95% confidence interval −0.5 to 3.8) and −0.4% (−2.0 to 1.2) with and without iron, respectively. Iron repletion did not affect any cognition or well-being measures. These data provide evidence that current criteria for blood donation preserve red cell transfusion quality for the recipient and protect adult donors from measurable effects of blood donation–induced iron deficiency on cognition. This trial was registered at www.clinicaltrials.gov as NCT02889133 and NCT02990559.
- 22 December 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (25) , 2730-2739
Open AccessA randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being
Although altruistic regular blood donors are vital for the blood supply, many become iron deficient from donation-induced iron loss. The effects of blood donation–induced iron deficiency on red cell transfusion quality or donor cognition are unknown. In this double-blind, randomized trial, adult iron-deficient blood donors (n = 79; ferritin < 15 μg/L and zinc protoporphyrin >60 μMol/mol heme) who met donation qualifications were enrolled. A first standard blood donation was followed by the gold-standard measure for red cell storage quality: a 51-chromium posttransfusion red cell recovery study. Donors were then randomized to intravenous iron repletion (1 g low-molecular-weight iron dextran) or placebo. A second donation ∼5 months later was followed by another recovery study. Primary outcome was the within-subject change in posttransfusion recovery. The primary outcome measure of an ancillary study reported here was the National Institutes of Health Toolbox–derived uncorrected standard Cognition Fluid Composite Score. Overall, 983 donors were screened; 110 were iron-deficient, and of these, 39 were randomized to iron repletion and 40 to placebo. Red cell storage quality was unchanged by iron repletion: mean change in posttransfusion recovery was 1.6% (95% confidence interval −0.5 to 3.8) and −0.4% (−2.0 to 1.2) with and without iron, respectively. Iron repletion did not affect any cognition or well-being measures. These data provide evidence that current criteria for blood donation preserve red cell transfusion quality for the recipient and protect adult donors from measurable effects of blood donation–induced iron deficiency on cognition. This trial was registered at www.clinicaltrials.gov as NCT02889133 and NCT02990559.
- 1 April 2022
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 25 (2) , 208-214
Clinical Characteristics and Fracture Patterns Among Postmenopausal Women with Isolated Osteoporosis at the Forearm
- 1 April 2022
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 25 (2) , 208-214
Clinical Characteristics and Fracture Patterns Among Postmenopausal Women with Isolated Osteoporosis at the Forearm
- 1 November 2021
- Published by Elsevier in Diabetes & Metabolism
- Vol. 47 (6) , 101267
Diabetic ketoacidosis and mortality in COVID-19 infection
- 1 November 2021
- Published by Elsevier in Diabetes & Metabolism
- Vol. 47 (6) , 101267
Diabetic ketoacidosis and mortality in COVID-19 infection
- 12 August 2021
- Published by Springer Nature in Osteoporosis International
- Vol. 33 (1) , 239-250
Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial
Summary Pelvic fracture patients were randomized to blinded daily subcutaneous teriparatide (TPTD) or placebo to assess healing and functional outcomes over 3 months. With TPTD, there was no evidence of improved healing by CT or pain reduction; however, physical performance improved with TPTD but not placebo (group difference p < 0.03). Introduction To determine if teriparatide (20 μg/day; TPTD) results in improved radiologic healing, reduced pain, and improved functional outcome vs placebo over 3 months in pelvic fracture patients. Methods This randomized, placebo-controlled study enrolled 35 patients (women and men >50 years old) within 4 weeks of pelvic fracture and evaluated the effect of blinded TPTD vs placebo over 3 months on fracture healing. Fracture healing from CT images at 0 and 3 months was assessed as cortical bridging using a 5-point scale. The numeric rating scale (NRS) for pain was administered monthly. Physical performance was assessed monthly by Continuous Summary Physical Performance Score (based on 4 m walk speed, timed repeated chair stands, and balance) and the Timed Up and Go (TUG) test. Results The mean age was 82, and >80% were female. The intention to treat analysis showed no group difference in cortical bridging score, and 50% of fractures in TPTD-treated and 53% of fractures in placebo-treated patients were healed at 3 months, unchanged after adjustment for age, sacral fracture, and fracture displacement. Median pain score dropped significantly in both groups with no group differences. Both CSPPS and TUG improved in the teriparatide group, whereas there was no improvement in the placebo group (group difference p < 0.03 for CSPPS at 2 and 3 months). Conclusion In this small randomized, blinded study, there was no improvement in radiographic healing (CT at 3 months) or pain with TPTD vs placebo; however, there was improved physical performance in TPTD-treated subjects that was not evident in the placebo group.
- 12 August 2021
- Published by Springer Nature in Osteoporosis International
- Vol. 33 (1) , 239-250
Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial
Summary Pelvic fracture patients were randomized to blinded daily subcutaneous teriparatide (TPTD) or placebo to assess healing and functional outcomes over 3 months. With TPTD, there was no evidence of improved healing by CT or pain reduction; however, physical performance improved with TPTD but not placebo (group difference p < 0.03). Introduction To determine if teriparatide (20 μg/day; TPTD) results in improved radiologic healing, reduced pain, and improved functional outcome vs placebo over 3 months in pelvic fracture patients. Methods This randomized, placebo-controlled study enrolled 35 patients (women and men >50 years old) within 4 weeks of pelvic fracture and evaluated the effect of blinded TPTD vs placebo over 3 months on fracture healing. Fracture healing from CT images at 0 and 3 months was assessed as cortical bridging using a 5-point scale. The numeric rating scale (NRS) for pain was administered monthly. Physical performance was assessed monthly by Continuous Summary Physical Performance Score (based on 4 m walk speed, timed repeated chair stands, and balance) and the Timed Up and Go (TUG) test. Results The mean age was 82, and >80% were female. The intention to treat analysis showed no group difference in cortical bridging score, and 50% of fractures in TPTD-treated and 53% of fractures in placebo-treated patients were healed at 3 months, unchanged after adjustment for age, sacral fracture, and fracture displacement. Median pain score dropped significantly in both groups with no group differences. Both CSPPS and TUG improved in the teriparatide group, whereas there was no improvement in the placebo group (group difference p < 0.03 for CSPPS at 2 and 3 months). Conclusion In this small randomized, blinded study, there was no improvement in radiographic healing (CT at 3 months) or pain with TPTD vs placebo; however, there was improved physical performance in TPTD-treated subjects that was not evident in the placebo group.
- 1 June 2021
- Published by Elsevier in Endocrine Practice
- Vol. 27 (6) , S97
Abstract #1003276: Increased Fracture Prevalence Among Older Women with Isolated Osteoporosis at the Forearm
- 1 June 2021
- Published by Elsevier in Endocrine Practice
- Vol. 27 (6) , S97
Abstract #1003276: Increased Fracture Prevalence Among Older Women with Isolated Osteoporosis at the Forearm